loadpatents
name:-0.0086729526519775
name:-0.0084850788116455
name:-0.0014770030975342
Herlyn; Dorothee Patent Filings

Herlyn; Dorothee

Patent Applications and Registrations

Patent applications and USPTO patent grants for Herlyn; Dorothee.The latest application filed is for "methods and compositions for treating melanoma".

Company Profile
1.7.7
  • Herlyn; Dorothee - Wynnewood PA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods and Compositions for Treating Melanoma
App 20220177548 - Somasundaram; Rajasekharan ;   et al.
2022-06-09
Methods and compositions for treating melanoma
Grant 11,208,468 - Somasundaram , et al. December 28, 2
2021-12-28
Methods and Compositions for Treating Melanoma
App 20190276517 - Somasundaram; Rajasekharan ;   et al.
2019-09-12
Method for Identifying a MHC Class H-Dependent Tumor Associated T Helper Cell Antigen
App 20100303833 - Herlyn; Dorothee ;   et al.
2010-12-02
Methods and compositions for treating melanoma
Grant 7,811,993 - Herlyn , et al. October 12, 2
2010-10-12
Methods and Compositions for Treating Melanoma
App 20100203109 - Herlyn; Dorothee ;   et al.
2010-08-12
Method for Identifying a MHC Class II-Dependent Tumor-Associated T Helper Cell Antigen
App 20100080792 - Herlyn; Dorothee ;   et al.
2010-04-01
Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic T lymphocyte activity
Grant 7,544,465 - Herlyn , et al. June 9, 2
2009-06-09
Methods and compositions for monitoring cell migration and identifying clinically relevant cytotoxic t lymphocyte activity
App 20060073469 - Herlyn; Dorothee ;   et al.
2006-04-06
Soluble variants of type I membrane proteins, and methods of using them
Grant 6,645,498 - Linnenbach , et al. November 11, 2
2003-11-11
Soluble variants of type I membrane proteins, and methods of using them
App 20030103935 - Linnenbach, Alban J. ;   et al.
2003-06-05
Cytolytic T-cell clones against colorectal carcinoma
Grant 6,528,307 - Herlyn March 4, 2
2003-03-04
Human tumor therapy using beta (1-3) glucanlentinan and anti-tumor antibodies
Grant 5,130,127 - Herlyn July 14, 1
1992-07-14
Induction of antibody response to solid tumors with anti-idiotype antibodies
Grant 5,053,224 - Koprowski , et al. October 1, 1
1991-10-01
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed